WVP
COYA icon

Worth Venture Partners’s Coya Therapeutics COYA Stock Holding History

Worth Venture Partners’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-92,667
Closed -$687K – 85
2023
Q4 		$687K Sell
92,667
-41,339
-31% -$229K 0.37% 67
2023
Q3 		$519K Sell
134,006
-12,487
-9% -$49.7K 0.31% 80
2023
Q2 		$596K Buy
146,493
+8,735
+6% +$40.5K 0.32% 70
2023
Q1 		$543K Hold
137,758
– – 0.26% 81
2022
Q4 		$638K Buy
+137,758
New +$641K 0.38% 65

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Worth Venture Partners's COYA Position: Q1 2024 in Review

Worth Venture Partners sold out of Coya Therapeutics (COYA) in Q1 2024, closing a stake of 92,667 shares — an estimated $687K sold.

Worth Venture Partners first reported a position in COYA in Q4 2022 and held it in 5 quarters. The position peaked at $687K in Q4 2023. 19 funds tracked by Wall St. Rank hold COYA as of Q1 2024.

  • Worth Venture Partners reported no remaining Coya Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Worth Venture Partners sold 92,667 Coya Therapeutics shares in Q1 2024, an estimated $687K.
  • Worth Venture Partners first reported a position in Coya Therapeutics in Q4 2022 and held it in 5 quarters.
  • Worth Venture Partners's Coya Therapeutics position peaked at $687K in Q4 2023.
  • 19 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2024.

Based on Worth Venture Partners's 13F filing for Q1 2024, filed 13 May 2024.